PCDH17 gene promoter demethylation and cell cycle arrest by genistein in gastric cancer

Histology and Histopathology

Volumn 27, Issue 2, 2012, Pages 217-224

  Yang, Yueqin ^a   Liu, Jia ^a   Li, Xiang ^a   Li, Ji Cheng ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

DNA methylation; Gastric cancer; Geinstein; PCDH17

Indexed keywords

ANTINEOPLASTIC AGENT; CADHERIN; GENISTEIN; PROTOCADHERIN 17, HUMAN;

ARTICLE; CELL CYCLE CHECKPOINT; CELL SEPARATION; CPG ISLAND; DNA METHYLATION; DRUG EFFECT; FLOW CYTOMETRY; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH TUMOR;

ANTICARCINOGENIC AGENTS; BASE SEQUENCE; CADHERINS; CELL CYCLE CHECKPOINTS; CELL SEPARATION; CPG ISLANDS; DNA METHYLATION; FLOW CYTOMETRY; GENE EXPRESSION; GENISTEIN; HUMANS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS;

EID: 84863281535     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Baylin S.B. and Ohm J.E. (2006). Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat. Rev. Cancer. 6, 107-116.
2. Bender C.M., Pao M.M. and Jones P.A. (1998). Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res. 58, 95-101.
3. Buffart T.E., Overmeer R.M., Steenbergen R.D., Tijssen M., van Grieken N.C., Snijders P.J., Grabsch H.I., van de Velde C.J., Carvalho B. and Meijer G.A. (2008). MAL promoter hypermethylation as a novel prognostic marker in gastric cancer. Br. J. Cancer 99, 1802-1807.
4. Cappelletti V., Fioravanti L., Miodini P. and Di Fronzo G. (2000). Genistein blocks breast cancer cells in the G(2)M phase of the cell cycle. J. Cell. Biochem. 79, 594-600
5. Chang K.L., Kung M.L., Chow N.H. and Su S.J. (2004). Genistein arrests hepatoma cells at G2/M phase: involvement of ATM activation and upregulation of p21waf1/cip1 and Wee1. Biochem. Pharmacol. 67, 717-726.
6. Chang K.L., Cheng H.L., Huang L.W., Hsieh B.S., Hu Y.C., Chih T.T., Shyu H.W. and Su S.J. (2009). Combined effects of terazosin and genistein on a metastatic, hormone-independent human prostate cancer cell line. Cancer Lett. 276, 14-20.
7. Dammann R., Schagdarsurengin U., Strunnikova M., Rastetter M., Seidel C., Liu L., Tommasi S. and Pfeifer G.P. (2003). Epigenetic inactivation of the Ras-association domain family 1 (RASSF1A) gene and its function in human carcinogenesis. Histol. Histopathol. 18, 665-677.
8. Dote H., Toyooka S., Tsukuda K., Yano M., Ota T., Murakami M., Naito M., Toyota M., Gazdar A.F. and Shimizu N. (2005). Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour. Br. J. Cancer 92, 1117-1125.
9. Imoto I., Izumi H., Yokoi S., Hosoda H., Shibata T., Hosoda F., Ohki M., Hirohashi S. and Inazawa J. (2006). Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers. Cancer Res. 66, 4617-4626.
10. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T. and Thun M.J. (2008). Cancer statistics, 2008. C.A. Cancer. J. Clin. 58, 71-96.
11. Jones P.A. and Baylin S.B. (2002). The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3, 415-428.
12. Jones P.A. and Laird P.W. (1999). Cancer epigenetics comes of age. Nat. Genet. 21, 163-167.
13. Jung Y., Park J., Bang Y.J. and Kim T.Y. (2008). Gene silencing of TSPYL5 mediated by aberrant promoter methylation in gastric cancers. Lab Invest. 88, 153-160.
14. Kikuno N., Shiina H., Urakami S., Kawamoto K., Hirata H., Tanaka Y., Majid S., Igawa M. and Dahiya R. (2008). Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells. Int. J. Cancer 123, 552-560.
15. Lian F., Bhuiyan M., Li Y.W., Wall N., Kraut M. and Sarkar F.H. (1998). Genistein-induced G2-M arrest, p21WAF1 upregulation, and apoptosis in a non-small-cell lung cancer cell line. Nutr. Cancer 31, 184-191.
16. Majid S., Kikuno N., Nelles J., Noonan E., Tanaka Y., Kawamoto K., Hirata H., Li L.C., Zhao H., Okino S.T., Place R.F., Pookot D. and Dahiya R. (2008). Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification. Cancer Res. 68, 2736-2744.
17. Majid S., Dar A.A., Ahmad A.E., Hirata H., Kawakami K., Shahryari V., Saini S., Tanaka Y., Dahiya A.V., Khatri G. and Dahiya R. (2009). BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis 30, 662-670.
18. Marsit C.J., Okpukpara C., Danaee H. and Kelsey K.T. (2005). Epigenetic silencing of the PRSS3 putative tumor suppressor gene in non-small cell lung cancer. Mol. Carcinog. 44, 146-150.
19. Molinari M. (2000). Cell cycle checkpoints and their inactivation in human cancer. Cell Prolif. 33, 261-274.
20. Momparler R.L. and Bovenzi V. (2000). DNA methylation and cancer. J. Cell Physiol. 183, 145-154.
21. Morishita H. and Yagi T. (2007). Protocadherin family: diversity, structure, and function. Curr. Opin. Cell Biol. 19, 584-592.
22. Narayan G., Scotto L., Neelakantan V., Kottoor S.H., Wong A.H., Loke S.L., Mansukhani M., Pothuri B., Wright J.D., Kaufmann A.M., Schneider A., Arias-Pulido H., Tao Q. and Murty V.V. (2009). Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer. Genes Chromosomes Cancer 48, 983-992.
23. Nardone G. (2003). Review article: molecular basis of gastric carcinogenesis. Aliment. Pharmacol. Ther. 17 (Supp 2), 75-81.
24. Ouyang G., Yao L., Ruan K., Song G., Mao Y. and Bao S. (2009). Genistein induces G2/M cell cycle arrest and apoptosis of human ovarian cancer cells via activation of DNA damage checkpoint pathways. Cell. Biol. Int. 33, 1237-1244.
25. Polkowski K. and Mazurek A. P. (2000). Biological properties of genistein. A review of in vitro and in vivo data. Acta. Pol. Pharm. 57, 135-155.
26. Raffoul J.J., Wang Y., Kucuk O., Forman J.D., Sarkar F.H. and Hillman G.G. (2006). Genistein inhibits radiation-induced activation of NFkappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest. BMC. Cancer 6, 107.
27. Tomii K., Tsukuda K., Toyooka S., Dote H., Hanafusa T., Asano H., Naitou M., Doihara H., Kisimoto T., Katayama H., Pass H.I., Date H. and Shimizu N. (2007). Aberrant promoter methylation of insulin-like growth factor binding protein-3 gene in human cancers. Int. J. Cancer 120, 566-573.
28. Upadhyay S., Neburi M., Chinni S.R., Alhasan S., Miller F. and Sarkar F.H. (2001). Differential sensitivity of normal and malignant breast epithelial cells to genistein is partly mediated by p21(WAF1). Clin. Cancer Res. 7, 1782-1789.
29. Valachovicova T., Slivova V. and Sliva D. (2004). Cellular and physiological effects of soy flavonoids. Mini. Rev. Med. Chem. 4, 881-887.
30. Verma M. and Srivastava S. (2002). Epigenetics in cancer: implications for early detection and prevention. Lancet Oncol. 3, 755-763.
31. Wanajo A., Sasaki A., Nagasaki H., Shimada S., Otsubo T., Owaki S., Shimizu Y., Eishi Y., Kojima K., Nakajima Y., Kawano T., Yuasa Y. and Akiyama Y. (2008). Methylation of the calcium channel-related gene, CACNA2D3, is frequent and a poor prognostic factor in gastric cancer. Gastroenterology 135, 580-590.
32. Wang Z. and Chen H. (2010). Genistein increases gene expression by demethylation of WNT5a promoter in colon cancer cell line SW1116. Anticancer Res. 30, 4537-4545.
33. Ying J., Li H., Seng T.J., Langford C., Srivastava G., Tsao S.W., Putti T., Murray P., Chan A.T. and Tao Q. (2006). Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Oncogene 25, 1070-1080.
34. Yu B., Yang H., Zhang C., Wu Q., Shao Y., Zhang J., Guan M., Wan J. and Zhang W. (2010). High-resolution melting analysis of PCDH10 methylation levels in gastric, colorectal and pancreatic cancers. Neoplasma 57, 247-252.
35. Yu J.S., Koujak S., Nagase S., Li C.M., Su T., Wang X., Keniry M., Memeo L., Rojtman A., Mansukhani M., Hibshoosh H., Tycko B. and Parsons R. (2008). PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer. Oncogene 27, 4657-4665.
36. Zou X.P., Zhang B., Zhang X.Q., Chen M., Cao J. and Liu W. J. (2009). Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. Hum. Pathol. 40, 1534-1542.